The Standard Group Plc is a multi-media organization with investments in media
platforms spanning newspaper print
operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a
leading multi-media house in Kenya with a key influence in matters of national
and international interest.
A new global health initiative led by Gavi, the Vaccine Alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI) is aiming to fast-track the development of a trial-ready vaccine for the Bundibugyo strain of Ebola virus within months, marking a major shift away from the traditional approach of waiting for outbreaks before starting vaccine development.
Gavi said the strategy is designed to close a long-standing gap in global epidemic preparedness, where rare and unpredictable pathogens receive limited commercial investment due to uncertain market returns. According to Gavi, this lack of demand certainty has historically slowed or discouraged manufacturers from investing in vaccines for less common Ebola strains such as Bundibugyo.
Facts First
This story continues on The Standard INSiDER. Subscribe now for unfiltered journalism that holds power to account.
Already have an account? Login
join